Delivery Order SPE2DB20D2104-SPE2DB24FS29A
Award Date
1/29/24
Potential Completion Date
1/30/24
Potential Value
$26K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products and medical supplies, including Myrbetriq ER 25 mg tablets, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $27,649.35, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $26,730.25 for the supply of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $26,730.25 and an ultimate completion date of February 6, 2024. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $57,498.35 for the pharmaceutical product Myrbetriq ER 50 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Myrbetriq ER 50 mg tablets. The award, valued at $11,755.04, was made by the Defense Logistics Agency (DLA) on November 3, 2021, with a completion date of November 4, 2021. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which runs through December 31, 2025....
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,342.94 for the pharmaceutical product Myrbetriq ER 25 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,964.07 delivery order is for the pharmaceutical product Myrbetriq ER 50 MG Tablet 90S. The award has a firm fixed price and an ultimate completion date of March 24, 2022. Cencora, Inc., doing business as Amerisourcebergen, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $18,990.92 for the supply of Myrbetriq ER 25 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 19, 2022. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DX24FMCVF) valued at $7,216.05 for the supply of Myrbetriq ER 50 MG tablets. The contract, with a performance period through May 3, 2024, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,138.61 for the pharmaceutical product Myrbetriq ER 50 mg tablets. The contract was awarded on June 27, 2023, with a completion date of June 28, 2023, by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
The federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products, including the medication Myrbetriq ER 50 mg tablets. The $8,477.59 contract is a firm-fixed-price delivery order placed by the Defense Logistics Agency (DLA), a defense agency. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary...